Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 756359, 6 pages
http://dx.doi.org/10.1155/2015/756359
Research Article

A Pyrosequencing Assay for the Quantitative Methylation Analysis of GALR1 in Endometrial Samples: Preliminary Results

1Department of Cytopathology, “ATTIKON” University Hospital, University of Athens Medical School, 1 Rimini, Haidari, 12462 Athens, Greece
22nd Department of Gynecology, St. Savas Cancer Hospital, 171 Alexandras Avenue, 11522 Athens, Greece
3Department of Obstetrics and Gynecology, IASO Hospital, 37-39 Kifisias Avenue, Maroussi, 15123 Athens, Greece
43rd Department of Obstetrics and Gynecology, “ATTIKON” University Hospital, 1 Rimini, Haidari, 12462 Athens, Greece
52nd Department of Pathology, “ATTIKON” University Hospital, University of Athens Medical School, 1 Rimini, Haidari, 12462 Athens, Greece

Received 26 March 2015; Revised 3 June 2015; Accepted 4 June 2015

Academic Editor: Maria Lina Tornesello

Copyright © 2015 Christine Kottaridi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. G. Gallup and R. J. Stock, “Adenocarcinoma of the endometrium in women 40 years of age or younger,” Obstetrics & Gynecology, vol. 64, no. 3, pp. 417–420, 1984. View at Google Scholar · View at Scopus
  2. L. G. Koss, K. Schreiber, S. G. Oberlander, M. Moukhtar, H. S. Levine, and H. F. Moussouris, “Screening of asymptomatic women for endometrial cancer,” CA: A Cancer Journal for Clinicians, vol. 31, no. 5, pp. 300–317, 1981. View at Publisher · View at Google Scholar · View at Scopus
  3. R. I. Horwitz, A. R. Feinstein, S. M. Horwitz, and S. J. Robboy, “Necropsy diagnosis of endometrial cancer and detection-bias in case/control studies,” The Lancet, vol. 2, no. 8237, pp. 66–68, 1981. View at Google Scholar · View at Scopus
  4. P. A. Jones and S. B. Baylin, “The epigenomics of Cancer,” Cell, vol. 128, no. 4, pp. 683–692, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J. G. Herman and S. B. Baylin, “Gene silencing in cancer in association with promoter hypermethylation,” The New England Journal of Medicine, vol. 349, no. 21, pp. 2042–2054, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. L. Suvà, N. Riggi, and B. E. Bernstein, “Epigenetic reprogramming in cancer,” Science, vol. 340, no. 6127, pp. 1567–1570, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Shen and P. W. Laird, “Interplay between the cancer genome and epigenome,” Cell, vol. 153, no. 1, pp. 38–55, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Lichtenstein, N. V. Holm, P. K. Verkasalo et al., “Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland,” The New England Journal of Medicine, vol. 343, no. 2, pp. 78–85, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. L. J. Schouten, R. A. Goldbohm, and P. A. van den Brandt, “Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands cohort study,” International Journal of Gynecological Cancer, vol. 16, no. supplement 2, p. 492, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. B. Baylin and P. A. Jones, “A decade of exploring the cancer epigenome—biological and translational implications,” Nature Reviews Cancer, vol. 11, no. 10, pp. 726–734, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Jones, A. E. Teschendorff, Q. Li et al., “Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development,” PLoS Medicine, vol. 10, no. 11, Article ID e1001551, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. X. C. Zhou, S. C. Dowdy, K. C. Podratz, and S.-W. Jiang, “Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment,” Gynecologic Oncology, vol. 107, no. 1, pp. 143–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Rauch and B. Kofler, “The galanin system in cancer,” EXS, vol. 102, pp. 223–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. B. S. Henson, R. R. Neubig, I. Jang et al., “Galanin receptor 1 has anti-proliferative effects in oral squamous cell carcinoma,” The Journal of Biological Chemistry, vol. 280, no. 24, pp. 22564–22571, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Doufekas, R. Hadwin, R. Kandimalla et al., “GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer,” International Journal of Gynecological Cancer, vol. 23, no. 6, pp. 1050–1055, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Misawa, T. Kanazawa, Y. Misawa et al., “Galanin has tumor suppressor activity and is frequently inactivated by aberrant promoter methylation in head and neck cancer,” Translational Oncology, vol. 6, no. 3, pp. 338–346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Buccoliero, F. Castiglione, C. F. Gheri et al., “Liquid-based endometrial cytology: its possible value in postmenopausal asymptomatic women,” International Journal of Gynecological Cancer, vol. 17, no. 1, pp. 182–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Papaefthimiou, H. Symiakaki, P. Mentzelopoulou et al., “The role of liquid-based cytology associated with curettage in the investigation of endometrial lesions from postmenopausal women,” Cytopathology, vol. 16, no. 1, pp. 32–39, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Papaefthimiou, H. Symiakaki, P. Mentzelopoulou et al., “Study on the morphology and reproducibility of the diagnosis of endometrial lesions utilizing liquid-based cytology,” Cancer, vol. 105, no. 2, pp. 56–64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. E. Scully and H. E. Poulsen, Histological Typing of Female Genital Tract Tumours, Springer, Berlin, Germany, 2nd edition, 1994.
  21. R. M. Overmeer, J. A. Louwers, C. J. L. M. Meijer et al., “Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women,” International Journal of Cancer, vol. 129, no. 9, pp. 2218–2225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. C. DiMaggio, SAS for Epidemiologists: Applications and Methods, Springer, New York, NY, USA, 2013. View at Publisher · View at Google Scholar
  23. SAS Institute, “SAS Home Page,” Ed., 2014.
  24. D. Zygouris, A. Pouliakis, N. Margari et al., “Classification of endometrial lesions by nuclear morphometry features extracted from liquid-based cytology samples: a system based on logistic regression model,” Analytical and Quantitative Cytopathology and Histopathology, vol. 36, no. 4, pp. 189–198, 2014. View at Google Scholar
  25. R. Holliday, “The inheritance of epigenetic defects,” Science, vol. 238, no. 4824, pp. 163–170, 1987. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Banelli, S. Bonassi, I. Casciano et al., “Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients,” International Journal of Cancer, vol. 126, no. 3, pp. 656–668, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. S. Gutkind, “Cell growth control by G protein-coupled receptors: from signal transduction to signal integration,” Oncogene, vol. 17, no. 11, pp. 1331–1342, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. J. N. Bakkum-Gamez, N. Wentzensen, M. J. Maurer et al., “Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons,” Gynecologic Oncology, vol. 137, no. 1, pp. 14–22, 2015. View at Publisher · View at Google Scholar